European Heart Journal · 2018 · 311 citations · 23 references
MedicineCardiologyHealth Technology AssessmentInterventional CardiologyOutcomes ResearchClinical Trial DesignClinical TrialsCoronary AngioplastyCoronary Artery DiseaseEfficacy EvaluationMedical Device EvaluationBioresorbable ScaffoldsClinical Outcomes After Percutaneous Coronary InterventionCoronary StentingPatient Outcomes MeasurementRegulatory Approval PathwaysStandardizationStandardized Outcome DefinitionsVascular Scaffolds
ARC‑2 is a collaboration among academic research groups, device manufacturers, and regulators from the US, Europe, and Asia. The ARC‑2 initiative revisited and updated coronary device trial endpoint definitions to accommodate complex lesions, novel devices, and patient‑related outcomes, aiming to standardize these endpoints across studies. Through a series of in‑person meetings, stakeholders reviewed device and trial evolution and proposed updated definitions and patient‑outcome recommendations. Stakeholders endorse the consensus endpoint definitions, which are advocated for use in trials and will improve outcome interpretation and cross‑study comparison to evaluate device safety and efficacy.
The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed in 2007, to make them more suitable for use in clinical trials that include increasingly complex lesion and patient populations and incorporate novel devices such as bioresorbable vascular scaffolds. In addition, recommendations for the incorporation of patient-related outcomes in clinical trials are proposed. Academic Research Consortium-2 is a collaborative effort between academic research organizations in the United States and Europe, device manufacturers, and European, US, and Asian regulatory bodies. Several in-person meetings were held to discuss the changes that have occurred in the device landscape and in clinical trials and regulatory pathways in the last decade. The consensus-based end point definitions in this document are endorsed by the stakeholders of this document and strongly advocated for clinical trial purposes. This Academic Research Consortium-2 document provides further standardization of end point definitions for coronary device trials, incorporating advances in technology and knowledge. Their use will aid interpretation of trial outcomes and comparison among studies, thus facilitating the evaluation of the safety and effectiveness of these devices.
23
Clinical End Points in Coronary Stent Trials
Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
Roxana Mehran, Sunil V. Rao, Deepak L. Bhatt et al. · Circulation · 2011 · 4.4K citations
Medicine, Cardiology, Hematology +10
Third universal definition of myocardial infarction
Kristian Thygesen, Burkert Pieske, Steven P. Schulman et al. · European Heart Journal · 2012 · 3.1K citations
Third Universal Definition of Myocardial Infarction
Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe et al. · Circulation · 2012 · 3K citations · Full text